Xiao Wei Zhang found that activation of the IL-17A/STAT3 pathway can inhibit autophagy in liver cells, thus aggravating liver fibrosis, while an IL-17A inhibitor could reverse the development of fibrosis (69). Here, IL17A is linked to Hepatic fibrosis.